Casdin Capital, LLC Blueprint Medicines Corp Call Options Transaction History
Casdin Capital, LLC
- $1.16 Billion
- Q2 2024
Call Options
1 transactions
Others Institutions Holding BPMC
# of Institutions
340Shares Held
62MCall Options Held
987KPut Options Held
578K-
Black Rock Inc. New York, NY6.65MShares$572 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.54MShares$562 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.87MShares$505 Million0.08% of portfolio
-
Wellington Management Group LLP Boston, MA3.24MShares$278 Million0.06% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.46MShares$212 Million8.22% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.14B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...